期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
中成药治疗室性早搏的临床研究证据图 被引量:1
1
作者 张文杰 汤佳微 +6 位作者 李军 武佶 张印明 解紫从 张乐松 孟超 黄炫淳 《中国中药杂志》 CAS CSCD 北大核心 2024年第5期1397-1405,共9页
该研究运用证据图系统梳理中成药治疗室性早搏的临床研究,了解该领域的证据分布。通过检索PubMed、Cochrane Library、Web of Science、中国知网(CNKI)、万方(Wanfang)、维普(VIP)数据库中关于中成药治疗室性早搏的文献,检索日期为2016... 该研究运用证据图系统梳理中成药治疗室性早搏的临床研究,了解该领域的证据分布。通过检索PubMed、Cochrane Library、Web of Science、中国知网(CNKI)、万方(Wanfang)、维普(VIP)数据库中关于中成药治疗室性早搏的文献,检索日期为2016年1月至2022年12月。采用图表结合文字的方式对证据进行分析与展示。最终纳入文献164篇,包括干预性研究147篇、观察性研究4篇、系统评价13篇。结果共获得27种中成药,其中参松养心胶囊和稳心颗粒报告频次较高;临床用药存在超适应证使用现象;近年来国内外该领域发文量呈下降趋势;干预性研究的结局指标有8类,动态心电图、临床有效率、安全性、超声心动图报告频次较高,缺乏对β受体阻滞剂减停率、主要心血管事件和药物经济学指标的报告,评价维度单一;纳入文献整体质量较低,降低了研究结论的可信度。未来需更加规范临床用药,提高临床研究质量,开展临床综合评价,为中成药治疗室性早搏提供更健全的科学依据。 展开更多
关键词 中成药 室性早搏 随机对照试验 系统评价 观察性研究 证据图
原文传递
Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NFκB Pathway 被引量:10
2
作者 MA Ru-feng CHEN Guang +7 位作者 LI Hong-zheng ZHANG Yun LIU Yong-mei HE Hao-qiang LIU Chen-yue xie zi-cong ZHANG Zhen-peng WANG Jie 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2020年第12期897-904,共8页
Objective:To explore whether Panax notoginseng saponins(PNS)exhibits heart protective effect in myocardial infarction(MI)rats and to identify the potential signaling pathways involved.Methods:MI rats induced by ligati... Objective:To explore whether Panax notoginseng saponins(PNS)exhibits heart protective effect in myocardial infarction(MI)rats and to identify the potential signaling pathways involved.Methods:MI rats induced by ligating the left anterior descending(LAD)coronary artery were assigned to sham coronary artery ligation or coronary artery ligation.Totally 36 Sprague-Dawley rats were randomly divided into sham group(distilled water,n=9),MI group(distilled water,n=9),PNS group(PNS,40 mg/kg daily,n=9)and fosinopril group(FIP,1.2 mg/kg daily,n=9)according to a random number table.The left ventricular morphology and function were conducted by echocardiography.Histological alterations were evaluated by the stainings of HE and Masson.The serum levels of C reactive protein(CRP),tumor necrosis factorα(TNF-α),growth differentiation factor-15(GDF-15)and the ratio of metalloproteinase-9(MMP-9)and tissue inhibitor of MMP-9(TIMP-1)were determined by ELISA.The levels of activating transcription factor 3(ATF3),mitogen-activated protein kinase kinase 3(MAP2 K3),p38 mitogen-activated protein kinase(p38 MAPK),phosphorylation of p38 MAPK(p-p38 MAPK),transforming growth factor-β(TGF-β1),collagenⅠ,nuclear factor kappa B p65(NFκB p65),phosphorylation of NFκB p65(p-NFκB p65),and phosphorylation of inhibitory kappa Bα(p-IκBα)in hearts were measured by Western blot and immunohistochemical staining,respectively.Results:PNS improved cardiac function and fibrosis in MI rats(P<0.05).The serum levels of CRP,TNF-α,GDF-15 and the ratio of MMP9/TIMP1 were reversed by PNS in MI rats.The expressions of TGF-β1,collagenⅠ,MAP2 K3,p38 MAPK,p-p38 MAPK,NFκB p65,p-NFκB p65,and p-IκBαwere down-regulated,while ATF3 increased with the treatment of PNS(P<0.05).Conclusions:PNS may improve cardiac function and fibrosis in MI rats via regulating ATF3/MAP2 K3/p38 MAPK and NFκB signaling pathways.These results suggest the potential of PNS in preventing the development of ventricular remodeling in MI rats. 展开更多
关键词 Panax notoginseng saponins myocardial infarction ventricular remodeling inflammation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部